snc logo
AI Search Beta
Search Limit Reached
To ensure smooth performance and fair access for all users, AI searches are limited within a set timeframe. Please try again later.
Companies
Add Entity
snc-logo

Startup Nation Finder

My Watchlists
Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
Saved Searches
Following
Messaging
Notifications
About Us
Glossary

Your CSV is on the way

We’ve sent your CSV file to
send file

Provide your business email

To complete this action, please provide your Business email.

Verify your business email

You only need to verify it once.
We’ve sent a verification link to

Create Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
0/300
Notifications Settings
Public content (accessible by all Finder users)

Add to List

    Notifications settings

    Set Notifications
    Off
    Select notifications to recieve tooltip-info
    Select all

    Email Alerts

    Receive notifications via email

    No Notifications are selected

    Would you like to select any notifications?
    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Create Free Account
    Lock Icon
    Lock Icon
    8 Characters, Uppercase letter (A-Z),
    Lowercase letter (a-z), Digit (0-9)
    Lock Icon
    Passwords do not match
    Already have an account? Sign In
    Or continue with

    Verify your email

    We’ve sent a verification link to [email protected]
    Sign in
    Lock Icon
    Lock Icon
    Reset password
    Don't have an account? Create Account
    Or continue with

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    disclaimer-icon
    Summary generated by AI
    Read article
    snackbar-icon
    title
    message
    Search Startups

    Cells technology, Small/Medium Startups

    Filters
    Clear

    Search by tag 

    All of
    Any of
    None of

    Sector 

    Primary Sector 

    Target Customer 

    Core Technology (1)

    Funding Stage 

    Founded 

    From
    To

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models 

    Product Stage 

    Employees (3)

    Location 

    Status 
    Processing your search... This may take a moment
    105 Startups 2 In the News 3 Recently Updated
    • Total Funding
      $2.17B
      Raised
      130
      Events
    • Private Funding
      $1.13B
      Raised
      95
      Rounds
    • Public Offerings
      $928.4M
      Raised
      23
      Offerings
    • M&A
      $108.3M
      Raised
      12
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags
    Glion AI Biotherapeutics logo

    Glion AI Biotherapeutics

    STEALTH MODE
    Stealth Mode
    2023 B2B 1-10 Pre-Funding Undisclosed
    generic-drugs
    pharma-companies
    pharmaceuticals
    drug-design
    oncology
    stealthmode
    orphan-drug
    rare-diseases
    amyotrophic-lateral-sclerosis-(als)
    proteins
    degenerative-diseases
    ai-process-optimization
    autoimmune-diseases
    molecular-biology
    UroGen Pharma logo

    UroGen Pharma

    Public
    Urologic Oncology Therapies
    2004 B2B 201-500 Public $522.2M
    oncology
    drug-delivery
    sustained-release
    urology
    pharmaceuticals
    orphan-drug
    non-surgical
    pharma-companies
    drug-design
    cancer
    AGAM Biological Products logo

    AGAM Biological Products

    PRESUMED INACTIVE
    Collagen-based Products for Skin Wounds and Burns
    2008 B2B 1-10 Mature Undisclosed
    skin-care
    cosmetics
    dermatology
    tissue-regeneration
    pharmaceuticals
    Aleph Farms logo

    Aleph Farms

    Cellular Agriculture Technology
    2017 B2B2C 51-200 C $147.35M
    space-tech
    dual-use
    aerospace
    climate-tech
    tissue-regeneration
    biotechnology
    foodtech
    food-and-beverage
    alternative-protein
    3d-technology
    non-gmo
    astrospace
    astronautics
    Anchiano Therapeutics logo

    Anchiano Therapeutics

    PRESUMED INACTIVE
    Targeted Cancer Therapies Based on H19 Gene
    2004 B2B 1-10 Acquired $37.7M
    cancer
    biotechnology
    biopharmaceutical
    cell-therapy
    biopsy
    targeted-therapy
    pharma-companies
    AnserBio logo

    AnserBio

    Nanoparticle based delivery of p53 protein - addressing the most frequent mutation in cancer. -
    2017 B2B 1-10 Seed $6.45M
    biotechnology
    medical-technologies
    therapeutics
    oncology
    cancer
    cell-therapy
    nanotechnology
    ApoRx Biopharmaceuticals logo

    ApoRx Biopharmaceuticals

    Targeted Protein Degradation Drug Discovery
    2021 B2B 1-10 Pre-Funding Undisclosed
    oncology
    pharmaceuticals
    immunotherapy
    pharma-companies
    biotechnology
    drug-discovery
    drug-design
    biopharmaceutical
    cancer-therapy
    cancer
    Processing your search... This may take a moment
    Startup AI Search Beta
    Search notes

    Search Startups

    105 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $2.17B
      Raised
      130
      Events
    • Private Funding
      $1.13B
      Raised
      95
      Rounds
    • Public Offerings
      $928.4M
      Raised
      23
      Offerings
    • M&A
      $108.3M
      Raised
      12
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    Glion AI Biotherapeutics logo
    Raised
    Undisclosed
    Glion AI Biotherapeutics
    Stealth Mode
    Founded:2023
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Funding
    UroGen Pharma logo
    Raised
    $522.2M
    UroGen Pharma
    Public
    Urologic Oncology Therapies
    Founded:2004
    Business Model:B2B
    Employees:201-500
    Funding Stage:Public
    AGAM Biological Products logo
    Raised
    Undisclosed
    AGAM Biological Products
    PRESUMED INACTIVE
    Collagen-based Products for Skin Wounds and Burns
    Founded:2008
    Business Model:B2B
    Employees:1-10
    Funding Stage:Mature
    Aleph Farms logo
    Raised
    $147.35M
    Aleph Farms
    Cellular Agriculture Technology
    Founded:2017
    Business Model:B2B2C
    Employees:51-200
    Funding Stage:C
    Anchiano Therapeutics logo
    Raised
    $37.7M
    Anchiano Therapeutics
    PRESUMED INACTIVE
    Targeted Cancer Therapies Based on H19 Gene
    Founded:2004
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    AnserBio logo
    Raised
    $6.45M
    AnserBio
    Nanoparticle based delivery of p53 protein - addressing the most frequent mutation in cancer. -
    Founded:2017
    Business Model:B2B
    Employees:1-10
    Funding Stage:Seed
    ApoRx Biopharmaceuticals logo
    Raised
    Undisclosed
    ApoRx Biopharmaceuticals
    Targeted Protein Degradation Drug Discovery
    Founded:2021
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Funding
    Access Comprehensive Financial Analytics
    Create a free account to:
    • Explore detailed financial analytics.
    • Track company growth and size.
    • Connect with company team members.
    I already have access,
    I already have access,